Navigation Links
STAAR Surgical Provides Outlook on Third Quarter 2011 Revenue and Cash
Date:10/20/2011

of the Medipolis Eye Centre in Belgium.  It is also anticipated that a patient of Dr. Mertens who had a Visian V4c implanted about forty five days ago will participate.  This discussion will be moderated by Hans Blickensdoerfer, President of STAAR Europe, Latin America and the Middle East.  A question and answer session will follow.  

The dial-in number for the conference call is 877-941-9205 for domestic participants and 480-629-9835 for international participants.  In addition, to access the live video webcast of the call, just click the following link STAAR live-stream, or go to the Investor Information section of STAAR's website at www.staar.com.

A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will be available for seven days.  This replay can be accessed by dialing 800-406-7325 for domestic callers and 303-590-3030 for international callers, both using passcode 4478575#.  An archived webcast will also be available at www.staar.com.

Safe HarborAll statements in this press release that are not statements of historical fact are forward-looking statements, including statements about any of the following: projections of earnings, revenue, sales, profit margins, cash or any other financial items; the plans, strategies, and objectives of management for future operations or prospects for achieving such plans; prospects for increased sales as a result of CE Mark approval of new ICL designs; statements of belief; and any statements of assumptions underlying any of the foregoing.

These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from thos
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. STAAR Surgical Reports Progress on Japan Application for Approval of Visian Toric Implantable Collamer® Lens (TICL)
2. STAAR Surgical to Present at the 2011 Canaccord Genuity Growth Conference
3. STAAR Surgical Reports 19% Revenue Growth Second Quarter
4. STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000
5. STAAR Surgicals nanoFLEX™ Collamer® IOL Receives CE Mark Approval
6. STAAR Surgical Launches Second Phase of Visian ICL Direct-to-Consumer Advertising Campaign
7. STAAR Surgical Enters Into Distribution Agreement With Ellex in Australia
8. STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million
9. STAAR Surgicals Visian® ICL Surpasses 200,000 Implants
10. STAAR Surgical Reports Continued Double Digit Core Revenue Growth
11. STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Therapeutics, Inc. (NASDAQ: PTCT ) today announced ... fourth quarter and full year ended December 31, 2014. ... PTC. We are now a growing commercial-stage biopharma company, ... rare disease space," stated Stuart W. Peltz, Ph.D., Chief ... bring the first treatment for Duchenne muscular dystrophy to ...
(Date:2/27/2015)... TEL-AVIV, Israel , February 27, 2015 ... Unternehmen baut sein bahnbrechendes Überwachungssystem für kongestive ... weiter aus -   ... Medical Technologies, die ein neuartiges Herzüberwachungssystem für ... gab heute bekannt, dass sie ein Finanzierungsvorhaben ...
(Date:2/27/2015)... -- Bionik Laboratories Corp. (OTC:DWTPD), a Delaware ... Bionik Laboratories, Inc., a Toronto ... accredited investors of units consisting of its common stock ... million. Shares of the Company,s common stock will continue ... symbol "DWTPD" until FINRA,s approval of the ticker "BNKL." ...
Breaking Medicine Technology:PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3
... SAN DIEGO, March 1, 2011 Optimer Pharmaceuticals, Inc. (Nasdaq: ... present at the following investor conferences: Citi 2011 ... 10:00 a.m. Eastern Time at the Hilton New York Hotel ... Health Care Conference on Monday, March 7, 2011 at 4:45 ...
... March 1, 2011 Valeritas, Inc., ... and commercialization of innovative drug delivery solutions, announced ... has cleared the company,s V-Go Disposable Insulin Delivery ... the continuous subcutaneous delivery of insulin in preset ...
Cached Medicine Technology:Optimer Pharmaceuticals to Present at March 2011 Investor Conferences 2Valeritas Receives FDA 510(k) Clearance for the V-Go™ Disposable Insulin Delivery Device for Use with NovoLog® 2Valeritas Receives FDA 510(k) Clearance for the V-Go™ Disposable Insulin Delivery Device for Use with NovoLog® 3
(Date:2/27/2015)... (PRWEB) February 27, 2015 Legislation ... Committee, includes a pharmacy provision to help prevent ... the pharmacy counter. The Protecting the Integrity of ... Health Subcommittee Chairman Kevin Brady (R-TX) and Ranking ... address the prescription drug abuse epidemic and implement ...
(Date:2/27/2015)... The Dawn Greene Hospice, a 10-bed facility located ... on the Upper East Side, was officially dedicated and blessed ... Eminence Timothy Michael Cardinal Dolan. , Thomas J. Fahey, Jr., ... a member of the ArchCare Board of Trustees, presided over ... executive director of MMW, and Christina McInerney, president and CEO ...
(Date:2/27/2015)... February 27, 2015 Mediaplanet today announces ... Health,” a campaign that aims to bring blood health ... care conversation. The stories in this edition go beyond ... of clinical care, hard-hitting advocacy, research and technological strides ... According the American Cancer Society, approximately every 3 ...
(Date:2/27/2015)... Healthpointe is now performing arthroscopy ... or diseases affecting the elbow , wrist ... throughout Southern California, and are dedicated in providing ... related to the upper extremities. , Dr. ... board-certified and fully trained in treating an array ...
(Date:2/27/2015)... Dr. Christopher Saunders, a board certified plastic ... Chadds Ford, Pa., location. The spring special will run ... be priced at $3,950 with all fees included. , ... include more than $3,000 in MedSpa services offered at ... , Space is very limited, so those who are ...
Breaking Medicine News(10 mins):Health News:PCMA Statement on the ‘Protecting the Integrity of Medicare Act’ 2Health News:The Dawn Greene Hospice Is Officially Dedicated 2Health News:The Dawn Greene Hospice Is Officially Dedicated 3Health News:Know Your Blood: Raising Awareness through Mediaplanet’s “Blood Health” Campaign 2Health News:Healthpointe is Now Performing Arthroscopic Surgery Techniques for Elbow, Hand and Wrist Injuries and Diseases, such as certain Ganglion Cysts 2Health News:Dr. Christopher Saunders Announces Spring Breast Augmentation Special at $3,950 2Health News:Dr. Christopher Saunders Announces Spring Breast Augmentation Special at $3,950 3
... shot, study finds , , TUESDAY, March 24 (HealthDay News) -- ... the 1980s and 1990s contained DNA from human papillomavirus type ... study. , It also found that women diagnosed with HPV16- ... than those diagnosed with cancers associated with other HPV types. ...
... Human Cytomegalovirus Stimulates Telomerase Activity in Tissue Culture ... triggers expression of the telomerase reverse transcriptase (hTERT) ... cells grown in culture. , HCMV has been ... mechanism by which the virus acts has been ...
... 24 Dr. Janet Neigel and the staff at the ... much-anticipated May 3rd, Pre-Mother,s Day Open House. The Center, located ... Jersey, will open its doors on May 3rd, 2009 between ... healthy solutions to their various cosmetic needs. The Pre-Mother,s Day ...
... ate higher amounts of soy during childhood had a 58 ... published in Cancer Epidemiology, Biomarkers and Prevention , a ... breast cancer incidence rates have been four to seven times ... in China or Japan. However, when Asian women migrate to ...
... about the threat of tuberculosis and the toll it takes ... Day. , The TB-HIV co-infection crisis is twice as ... 2007, there were at least 1.37 million cases of HIV-positive ... double the previous WHO estimates. , "A global health ...
... Clinical Specialists to Present Clinical Experience at American Burn ... Nephew Inc,s Advanced Wound Management division (LSE: SN; NYSE: ... titled "Optimizing Outcomes in Burn Care" at the 41st ... this symposium, top burn specialists will present their clinical ...
Cached Medicine News:Health News:HPV Data May Aid Vaccine's Effectiveness 2Health News:Also in the March 24 JNCI 2Health News:Also in the March 24 JNCI 3Health News:Also in the March 24 JNCI 4Health News:Also in the March 24 JNCI 5Health News:Also in the March 24 JNCI 6Health News:Spring Forward with a New You! The Neigel Center for Cosmetic and Laser Surgery Hosts Its May 3rd Pre-Mother's Day Open House! 2Health News:Eating soy early in life may reduce breast cancer among Asian women 2Health News:Alarming new data shows TB-HIV co-infection a bigger threat 2Health News:Smith & Nephew Announces Symposium for Optimizing Outcomes in Burn Care 2Health News:Smith & Nephew Announces Symposium for Optimizing Outcomes in Burn Care 3Health News:Smith & Nephew Announces Symposium for Optimizing Outcomes in Burn Care 4
... CMC joint is the most common site for ... the CMC joint without restricting the wrist or ... persons who need to control or reduce subluxation ... perform work and leisure activities without pain. Also ...
... This is an excellent choice to treat ... MCP joint, basal joint arthritis, advanced carpal ... the thumb and wrist. Distal palmar ... flexion and full finger dexterity. Constructed ...
... CTi Wrist OTS is an off-the-shelf wrist orthotic designed ... of 3 pre-set ranges-of-motion (20°,35° and 50°). , ... sprains with TFCC tear-triangular fibrocartilage complex , ... nonunion , Partial tendon rupture , ...
... CTi Wrist Static is a solid, one-piece custom wrist ... stable, neutral position. , ,Indications: , Wrist ... fibrocartilage complex , Coles fracture - distal ... Partial tendon rupture , ORIF - Open ...
Medicine Products: